Observations reveal tetracyclic meroterpenoids reduce neuroinflammation in BV2 cells, suggesting new therapeutic strategies.
Three pairs of novel β-acid meroterpenoid enantiomers with an unprecedented 5/6/7/5 tetracyclic ring skeleton, (±)-humulunones A-C (1-3), were isolated from Humulus lupulus L. Their structures were elucidated by comprehensive spectroscopic data analysis, calculated NMR and electronic circular dichroism, and X-ray single-crystal diffraction. Compounds (+)-1, (-)-1, (+)-2, and (-)-2 exhibited significant anti-neuroinflammatory effects on LPS-induced BV2 cells. Furthermore, compound (-)-1 effectively ameliorated oxidative stress and inhibited NLRP3 inflammasome activation, demonstrating efficacy comparable to that of the classic inhibitor MCC950 in suppressing the expression of NLRP3, ASC, caspase-1, and downstream inflammatory factors. Molecular docking and a cellular thermal shift assay implied that (-)-1 exerted its anti-neuroinflammatory effect through potential interaction with the NLRP3 protein, which provided a fresh perspective for the drug development of neuroinflammatory-related diseases.
No takes yet. Share an insight, caveat, or question.
Ding et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: